Stock MBOT MICROBOT MEDICAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Microbot Medical Inc.

Equities

MBOT

US59503A2042

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-28 EDT 		5-day change 1st Jan Change
1.02 USD -0.97% Intraday chart for Microbot Medical Inc. -1.92% -37.80%
06-20 Microbot Medical Inc Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial CI
06-20 Microbot Medical Inc. announced that it has received $1.762502 million in funding CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial
GL
Microbot Medical Inc Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial
CI
Microbot Medical Inc. announced that it has received $1.762502 million in funding
CI
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial
GL
Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial
AQ
Microbot Medical Files Common Stock Registration Statement
MT
Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
GL
Sector Update: Health Care Stocks Gain Late Afternoon
MT
Microbot Gets FDA Nod to Start Trial, to Raise $2.35 Million From Direct Offering Deal; Shares Soar
MT
Top Midday Gainers
MT
Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
GL
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
GL
Microbot Medical Inc. Has Received FDA Approval to Proceed with Its Pivotal Human Clinical Trial
CI
Microbot Medical Inc. announced that it expects to receive $1.762502 million in funding
CI
Microbot Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™
GL
Microbot Medical Announces Positive Results from the First Phase of Its Collaboration with Corewell Health
CI
HC Wainwright Adjusts Microbot Medical's Price Target to $7 From $8, Keeps Buy Rating
MT
Microbot Medical Shares Status Following Recent Geopolitical Events
GL
Microbot Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MBOT Stock
  4. News Microbot Medical Inc.